(Q39873484)

15 September 2017

title

2-Phenylquinolones as inhibitors of the HIV-1 Tat-TAR interaction (English)

1 reference

15 September 2017

2

1 reference

15 September 2017

3

1 reference

15 September 2017

5

1 reference

15 September 2017

9

1 reference

15 September 2017

10

1 reference

15 September 2017

7

Cristina Parolin

1 reference

15 September 2017

Barbara Gatto

1

1 reference

15 September 2017

Giulia Giaretta

series ordinal

4

1 reference

15 September 2017

Claudia Del Vecchio

series ordinal

6

1 reference

15 September 2017

Arnaldo Fravolini

series ordinal

8

1 reference

15 September 2017

publication date

1 June 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

4

1 reference

15 September 2017

issue

6

1 reference

15 September 2017

page(s)

935-938

1 reference

New approaches toward anti-HIV chemotherapy

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800437

7 January 2021

Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800437

7 January 2021

The trans-activator gene of HTLV-III is essential for virus replication

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800437

7 January 2021

Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800437

7 January 2021

Targeting RNA with small molecules

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800437

7 January 2021

Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800437

7 January 2021

The design, synthesis, and biological evaluation of novel substituted purines as HIV-1 Tat-TAR inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800437

7 January 2021

Synthesis and biological evaluation of 2-phenylquinolones targeted at Tat/TAR recognition.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800437

7 January 2021

High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800437

7 January 2021

6-Aminoquinolones as new potential anti-HIV agents.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800437

7 January 2021

Identifiers

DOI

10.1002/CMDC.200800437

1 reference

15 September 2017

1 reference